Delic Corp Inc. (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, has announced that Glenn Sammis, a professor and scientific advisor to subsidiary Delic Labs, has received a full professorship at the University of British Columbia in the chemistry department. The announcement also noted that Sammis will be working closely with Dr. Markus Roggen in developing intellectual property (“IP”) for Delic Labs’ cannabis and psilocybin research; he will take a yearlong sabbatical from his position at the university to pursue this research. A federally authorized psilocybin and cannabis research laboratory, Delic Labs is focused on extraction, analytical testing and chemical process development. The facility conducts research and develops product lines for distribution through Delic Corp.’s existing network throughout the United States, including licensed psychedelic wellness clinics. In the announcement, Sammis noted that he looks forward to working with Roggen, calling it a “great honor.” He also noted that the company’s unique and early testing would give the company a first-mover advantage in the medical psychedelic space. Delic Labs was founded by Roggen and Sammis. According to the announcement, DELIC Labs is a leading cannabis analytical and research company with a client list that includes some of the best-known brands around the world. The lab is in the process of applying for a dealer’s license and anticipates commercializing its research and IP moving forward.
To view the full press release, visit https://ibn.fm/nhh87
About Delic Corp Inc.
Delic is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms such as Reality Sandwich; Delic Radio; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premiere psychedelic wellness event; and Ketamine Infusion Centers, one of the largest ketamine clinics in the country. Delic is backed by a team of industry and cannabis veterans and a diverse network whose mission is to provide education, research, high-quality products and treatment options to the masses. For more information about the company, visit www.DelicCorp.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php